Related references
Note: Only part of the references are listed.A dysregulated bile acid-gut microbiota axis contributes to obesity susceptibility
Meilin Wei et al.
EBIOMEDICINE (2020)
Ursodeoxycholic acid inhibits uptake and vasoconstrictor effects of taurocholate in human placenta
Emma M. Lofthouse et al.
FASEB JOURNAL (2019)
Ursodeoxycholic acid accelerates bile acid enterohepatic circulation
Yunjing Zhang et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
Mitochondrial oxysterol biosynthetic pathway gives evidence for CYP7B1 as controller of regulatory oxysterols
Gents Kakiyama et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2019)
Sterol 12α-Hydroxylase Aggravates Dyslipidemia by Activating the Ceramide/mTORC1/SREBP-1C Pathway via FGF21 and FGF15
Preeti Pathak et al.
GENE EXPRESSION (2019)
Theabrownin from Pu-erh tea attenuates hypercholesterolemia via modulation of gut microbiota and bile acid metabolism
Fengjie Huang et al.
NATURE COMMUNICATIONS (2019)
Tissue and serum metabolite profiling reveals potential biomarkers of human hepatocellular carcinoma
Jun Han et al.
CLINICA CHIMICA ACTA (2019)
Gut microbial profile is altered in primary biliary cholangitis and partially restored after UDCA therapy
Ruqi Tang et al.
GUT (2018)
Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis
Wei Jia et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
Tumor LXR Expression is a Prognostic Marker for Patients with Hepatocellular Carcinoma
Houyong Long et al.
PATHOLOGY & ONCOLOGY RESEARCH (2018)
Progress and challenges of selective Farnesoid X Receptor modulation
Vittoria Massafra et al.
PHARMACOLOGY & THERAPEUTICS (2018)
The gut-liver axis in hepatocarcinoma: a focus on the nuclear receptor FXR and the enterokine FGF19
Marilidia Piglionica et al.
CURRENT OPINION IN PHARMACOLOGY (2018)
Bile salt hydrolases: Structure and function, substrate preference, and inhibitor development
Zixing Dong et al.
PROTEIN SCIENCE (2018)
Attenuated Effects of Bile Acids on Glucose Metabolism and Insulin Sensitivity in a Male Mouse Model of Prenatal Undernutrition
Huijuan Ma et al.
ENDOCRINOLOGY (2017)
Bile Acid Control of Metabolism and Inflammation in Obesity, Type 2 Diabetes, Dyslipidemia, and Nonalcoholic Fatty Liver Disease
Oscar Chavez-Talavera et al.
GASTROENTEROLOGY (2017)
Increased hepatic ABCA1 transporter is associated with hypercholesterolemia in a cholestatic rat model and primary biliary cholangitis patients
Yasuaki Takeyama et al.
MEDICAL MOLECULAR MORPHOLOGY (2017)
Bile acid analysis in human disorders of bile acid biosynthesis
Frederic. M. Vaz et al.
MOLECULAR ASPECTS OF MEDICINE (2017)
Fibroblast growth factor 19 regulates skeletal muscle mass and ameliorates muscle wasting in mice
Berengere Benoit et al.
NATURE MEDICINE (2017)
Cold-induced conversion of cholesterol to bile acids in mice shapes the gut microbiome and promotes adaptive thermogenesis
Anna Worthmann et al.
NATURE MEDICINE (2017)
Cyp8b1 ablation prevents Western diet-induced weight gain and hepatic steatosis because of impaired fat absorption
Enrico Bertaggia et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2017)
Cholesterol metabolites and tumor microenvironment: the road towards clinical translation
Laura Raccosta et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2016)
Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23
Chiara Degirolamo et al.
NATURE REVIEWS DRUG DISCOVERY (2016)
Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism
Annika Wahlstrom et al.
CELL METABOLISM (2016)
Bile Acids Protect Expanding Hematopoietic Stem Cells from Unfolded Protein Stress in Fetal Liver
Valgardur Sigurdsson et al.
CELL STEM CELL (2016)
EnaBILEing Growth in the Fetal Liver
Wolfram Goessling et al.
CELL STEM CELL (2016)
The gut microbiota and metabolic disease: current understanding and future perspectives
T. Arora et al.
JOURNAL OF INTERNAL MEDICINE (2016)
Oxysterol binding protein-related protein 8 mediates the cytotoxicity of 25-hydroxycholesterol
Jiwei Li et al.
JOURNAL OF LIPID RESEARCH (2016)
Bile acid profiles in diabetic (db/db) mice and their wild type littermates
Chang Chen et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2016)
Chardonnay Grape Seed Flour Ameliorates Hepatic Steatosis and Insulin Resistance via Altered Hepatic Gene Expression for Oxidative Stress, Inflammation, and Lipid and Ceramide Synthesis in Diet-Induced Obese Mice
Kun-Ho Seo et al.
PLOS ONE (2016)
Oxysterols: From cholesterol metabolites to key mediators
Valentin Mutemberezi et al.
PROGRESS IN LIPID RESEARCH (2016)
Inhibition of ileal bile acid uptake protects against nonalcoholic fatty liver disease in high-fat diet-fed mice
Anuradha Rao et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Oxysterols in Metabolic Syndrome: From Bystander Molecules to Bioactive Lipids
Owein Guillemot-Legris et al.
TRENDS IN MOLECULAR MEDICINE (2016)
Bile acids evoke placental inflammation by activating Gpbar1/NF-κB pathway in intrahepatic cholestasis of pregnancy
YouHua Zhang et al.
Journal of Molecular Cell Biology (2016)
Uncoupling Nuclear Receptor LXR and Cholesterol Metabolism in Cancer
Fabiola Bovenga et al.
CELL METABOLISM (2015)
The Bile Acid Chenodeoxycholic Acid Increases Human Brown Adipose Tissue Activity
Evie P. M. Broeders et al.
CELL METABOLISM (2015)
A Liver-Enriched Long Non-Coding RNA, lncLSTR, Regulates Systemic Lipid Metabolism in Mice
Ping Li et al.
CELL METABOLISM (2015)
Oxysterol-binding Protein-related Protein 8 (ORP8) Increases Sensitivity of Hepatocellular Carcinoma Cells to Fas-Mediated Apoptosis
Wenbin Zhong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Chenodeoxycholic Acid as a Potential Prognostic Marker for Roux-en-Y Gastric Bypass in Chinese Obese Patients
Haoyong Yu et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Ursodeoxycholic acid exerts farnesoid X receptor-antagonistic effects on bile acid and lipid metabolism in morbid obesity
Michaela Mueller et al.
JOURNAL OF HEPATOLOGY (2015)
Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance
Sungsoon Fang et al.
NATURE MEDICINE (2015)
Farnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine L cells
Mohamed-Sami Trabelsi et al.
NATURE COMMUNICATIONS (2015)
Loss of Cyp8b1 Improves Glucose Homeostasis by Increasing GLP-1
Achint Kaur et al.
DIABETES (2015)
Insulin-Sensitizing Effect of LXR Agonist T0901317 in High-Fat Fed Rats is Associated with Restored Muscle GLUT4 Expression and Insulin-Stimulated AS160 Phosphorylation
Marcin Baranowski et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2014)
SREBP-1 Has a Prognostic Role and Contributes to Invasion and Metastasis in Human Hepatocellular Carcinoma
Chao Li et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
Bile acid receptors as targets for drug development
Frank G. Schaap et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2014)
Discovery of Bile Salt Hydrolase Inhibitors Using an Efficient High-Throughput Screening System
Katie Smith et al.
PLOS ONE (2014)
The Reversed Feto-Maternal Bile Acid Gradient in Intrahepatic Cholestasis of Pregnancy Is Corrected by Ursodeoxycholic Acid
Victoria Geenes et al.
PLOS ONE (2014)
Intrahepatic cholestasis of pregnancy and associated adverse pregnancy and fetal outcomes: a 12-year population-based cohort study
E. Wikstroem Shemer et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2013)
Pleiotropic Roles of Bile Acids in Metabolism
Thomas Q. de Aguiar Vallim et al.
CELL METABOLISM (2013)
Gut Microbiota Regulates Bile Acid Metabolism by Reducing the Levels of Tauro-beta-muricholic Acid, a Naturally Occurring FXR Antagonist
Sama I. Sayin et al.
CELL METABOLISM (2013)
Human Insulin Resistance Is Associated With Increased Plasma Levels of 12a-Hydroxylated Bile Acids
Rebecca A. Haeusler et al.
DIABETES (2013)
The oxysterol-CXCR2 axis plays a key role in the recruitment of tumor-promoting neutrophils
Laura Raccosta et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Oxysterol generation and liver X receptor-dependent reverse cholesterol transport: Not all roads lead to Rome
Parveer S. Pannu et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2013)
Decreased hepatotoxic bile acid composition and altered synthesis in progressive human nonalcoholic fatty liver disease
April D. Lake et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2013)
A specific cholesterol metabolic pathway is established in a subset of HCCs for tumor growth
Ming Lu et al.
JOURNAL OF MOLECULAR CELL BIOLOGY (2013)
5-Cholesten-3β,25-Diol 3-Sulfate Decreases Lipid Accumulation in Diet-Induced Nonalcoholic Fatty Liver Disease Mouse Model
Leyuan Xu et al.
MOLECULAR PHARMACOLOGY (2013)
25-Hydroxycholesterol-3-sulfate attenuates inflammatory response via PPARγ signaling in human THP-1 macrophages
Leyuan Xu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2012)
Fibroblast growth factor 19 expression correlates with tumor progression and poorer prognosis of hepatocellular carcinoma
Seiki Miura et al.
BMC CANCER (2012)
Increased Hepatic Synthesis and Dysregulation of Cholesterol Metabolism Is Associated with the Severity of Nonalcoholic Fatty Liver Disease
Hae-Ki Min et al.
CELL METABOLISM (2012)
Analysis of hepatic gene expression profile in a spontaneous mouse model of type 2 diabetes under a high sucrose diet
Koji Nojima et al.
ENDOCRINE JOURNAL (2012)
The ABCG5 ABCG8 Sterol Transporter Opposes the Development of Fatty Liver Disease and Loss of Glycemic Control Independently of Phytosterol Accumulation
Kai Su et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Increased serum liver X receptor ligand oxysterols in patients with non-alcoholic fatty liver disease
Tadashi Ikegami et al.
JOURNAL OF GASTROENTEROLOGY (2012)
Oxysterol sulfation by cytosolic sulfotransferase suppresses liver X receptor/sterol regulatory element binding protein-1c signaling pathway and reduces serum and hepatic lipids in mouse models of nonalcoholic fatty liver disease
Qianming Bai et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2012)
Host-Gut Microbiota Metabolic Interactions
Jeremy K. Nicholson et al.
SCIENCE (2012)
Association Between Composition of the Human Gastrointestinal Microbiome and Development of Fatty Liver With Choline Deficiency
Melanie D. Spencer et al.
GASTROENTEROLOGY (2011)
Suppression of ABCA1 by unsaturated fatty acids leads to lipid accumulation in HepG2 cells
Yanhong Yang et al.
BIOCHIMIE (2010)
Improved Glycemic Control with Colesevelam Treatment in Patients with Type 2 Diabetes Is Not Directly Associated with Changes in Bile Acid Metabolism
Gemma Brufau et al.
HEPATOLOGY (2010)
Tumor-mediated liver X receptor-alpha activation inhibits CC chemokine receptor-7 expression on dendritic cells and dampens antitumor responses
Eduardo J. Villablanca et al.
NATURE MEDICINE (2010)
Acyl-coenzyme A: cholesterol acyltransferases
Ta-Yuan Chang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2009)
Liver X Receptor Mediates Hepatitis B Virus X Protein-Induced Lipogenesis in Hepatitis B Virus-Associated Hepatocellular Carcinoma
Tae-Young Na et al.
HEPATOLOGY (2009)
Enhanced free cholesterol, SREBP-2 and StAR expression in human NASH
Francisco Caballero et al.
JOURNAL OF HEPATOLOGY (2009)
Oxysterols: Sources, cellular storage and metabolism, and new insights into their roles in cholesterol homeostasis
Andrew J. Brown et al.
MOLECULAR ASPECTS OF MEDICINE (2009)
Bile acids: Chemistry, physiology, and pathophysiology
Maria J. Monte et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
Inhibition of fibroblast growth factor 19 reduces tumor growth by modulating β-catenin signaling
Rama Pai et al.
CANCER RESEARCH (2008)
Liver X receptor in cooperation with SREBP-1c is a major lipid synthesis regulator in nonalcoholic fatty liver disease
Nobito Higuchi et al.
HEPATOLOGY RESEARCH (2008)
Hepatic insulin resistance directly promotes formation of cholesterol gallstones
Sudha B. Biddinger et al.
NATURE MEDICINE (2008)
Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine
Insook Kim et al.
JOURNAL OF LIPID RESEARCH (2007)
Sulfated oxysterol, 25HC3S, is a potent regulator of lipid metabolism in human hepatocytes
Shunlin Ren et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Bile salt biotransformations by human intestinal bacteria
JM Ridlon et al.
JOURNAL OF LIPID RESEARCH (2006)
Micellization of conjugated chenodeoxy- and ursodeoxycholates and solubilization of cholesterol into their micelles: comparison with other four conjugated bile salts species
K Matsuoka et al.
CHEMISTRY AND PHYSICS OF LIPIDS (2006)
ATP-binding cassette transporter A1: A cell cholesterol exporter that protects against cardiovascular disease
JF Oram et al.
PHYSIOLOGICAL REVIEWS (2005)
Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: Results of a randomized trial
KD Lindor et al.
HEPATOLOGY (2004)
Fibroblast growth factor 19 increases metabolic rate I and reverses dietary and leptlin-deficient diabetes
L Fu et al.
ENDOCRINOLOGY (2004)
Cloning and characterization of the NAD-dependent 7α-hydroxysteroid dehydrogenase from Bacteroides fragilis
MJ Bennett et al.
CURRENT MICROBIOLOGY (2003)
Feeding natural hydrophilic bile acids inhibits intestinal cholesterol absorption: studies in the gallstone-susceptible mouse
DQH Wang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2003)
Activation of liver X receptor improves glucose tolerance through coordinate regulation of glucose metabolism in liver and adipose tissue
BA Laffitte et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Lipopolysaccharides in liver injury: molecular mechanisms of Kupffer cell activation
GL Su
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2002)
Analysis of theaflavins in biological fluids using liquid chromatography-electrospray mass spectrometry
TPJ Mulder et al.
JOURNAL OF CHROMATOGRAPHY B (2001)
Hepatic taurine, glycine and individual bile acids an early human fetus
S Itoh et al.
EARLY HUMAN DEVELOPMENT (2000)
Share Paper
